StockData
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS) stock

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.44+0.03 (+2.13%)

Close on Nov 17, 2026Market cap $120.11MP/E –Yield –

Pyxis Oncology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Pyxis Oncology's operating cash flow for the twelve months ending Jun 30, 2026 was -$67.91M. For fiscal 2025 it was -$63.50M. The highest annual figure on record is -$10.08M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$63.50M–
FY2024Dec 31, 2024-$57.67M–
FY2023Dec 31, 2023-$70.71M–
FY2022Dec 31, 2022-$89.34M–
FY2021Dec 31, 2021-$35.33M–
FY2020Dec 31, 2020-$10.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$18.21M–
Q1 FY2026Mar 31, 2026-$26.00M–
Q4 FY2025Dec 31, 2025-$10.43M–
Q3 FY2025Sep 30, 2025-$13.28M–
Q2 FY2025Jun 30, 2025-$17.26M–
Q1 FY2025Mar 31, 2025-$22.54M–
Q4 FY2024Dec 31, 2024-$19.29M–
Q3 FY2024Sep 30, 2024-$14.67M–
Q2 FY2024Jun 30, 2024-$3.01M–
Q1 FY2024Mar 31, 2024-$20.71M–
Q4 FY2023Dec 31, 2023-$15.25M–
Q3 FY2023Sep 30, 2023-$17.58M–
Q2 FY2023Jun 30, 2023-$11.03M–
Q1 FY2023Mar 31, 2023-$26.84M–
Q4 FY2022Dec 31, 2022-$17.39M–
Q3 FY2022Sep 30, 2022-$20.56M–
Q2 FY2022Jun 30, 2022-$23.71M-928.5%
Q1 FY2022Mar 31, 2022-$27.68M–
Q4 FY2021Dec 31, 2021-$12.17M–
Q3 FY2021Sep 30, 2021-$7.29M–
Q2 FY2021Jun 30, 2021$2.86M–
Q1 FY2021Mar 31, 2021-$18.73M–
Q4 FY2020Dec 31, 2020-$3.17M–

More Pyxis Oncology figures

See a number that looks wrong?